The global market for Opioid Analgesics was valued at US$ 36830 million in the year 2024 and is projected to reach a revised size of US$ 55780 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Opioid Analgesics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Analgesics.

The Opioid Analgesics market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioid Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Opioid Analgesics Market Report

Report Metric	Details
Report Name	Opioid Analgesics Market
Accounted market size in year	US$ 36830 million
Forecasted market size in 2031	US$ 55780 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	OxyContin Vicodin Morphine Methadone Others
Segment by Application	Surgical Pain Cancer Pain Neuropathic Pain Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health, Sanofi S.A., Teva Pharmaceuticals, Purdue Pharmaceuticals L.P., Endo International Plc, Assertio Holdings, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioid Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Opioid Analgesics Market growing?

Ans: The Opioid Analgesics Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Opioid Analgesics Market size in 2031?

Ans: The Opioid Analgesics Market size in 2031 will be US$ 55780 million.

Who are the main players in the Opioid Analgesics Market report?

Ans: The main players in the Opioid Analgesics Market are Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health, Sanofi S.A., Teva Pharmaceuticals, Purdue Pharmaceuticals L.P., Endo International Plc, Assertio Holdings, Inc

What are the Application segmentation covered in the Opioid Analgesics Market report?

Ans: The Applications covered in the Opioid Analgesics Market report are Surgical Pain, Cancer Pain, Neuropathic Pain, Others

What are the Type segmentation covered in the Opioid Analgesics Market report?

Ans: The Types covered in the Opioid Analgesics Market report are OxyContin, Vicodin, Morphine, Methadone, Others

1 Opioid Analgesics Market Overview

1.1 Product Definition

1.2 Opioid Analgesics by Type

1.2.1 Global Opioid Analgesics Market Value Comparison by Type (2024 VS 2031)

1.2.2 OxyContin

1.2.3 Vicodin

1.2.4 Morphine

1.2.5 Methadone

1.2.6 Others

1.3 Opioid Analgesics by Application

1.3.1 Global Opioid Analgesics Market Value by Application (2024 VS 2031)

1.3.2 Surgical Pain

1.3.3 Cancer Pain

1.3.4 Neuropathic Pain

1.3.5 Others

1.4 Global Opioid Analgesics Market Size Estimates and Forecasts

1.4.1 Global Opioid Analgesics Revenue 2020-2031

1.4.2 Global Opioid Analgesics Sales 2020-2031

1.4.3 Global Opioid Analgesics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Opioid Analgesics Market Competition by Manufacturers

2.1 Global Opioid Analgesics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Opioid Analgesics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Opioid Analgesics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Opioid Analgesics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Opioid Analgesics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Opioid Analgesics, Product Type & Application

2.7 Global Key Manufacturers of Opioid Analgesics, Date of Enter into This Industry

2.8 Global Opioid Analgesics Market Competitive Situation and Trends

2.8.1 Global Opioid Analgesics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Opioid Analgesics Players Market Share by Revenue

2.8.3 Global Opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Opioid Analgesics Market Scenario by Region

3.1 Global Opioid Analgesics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Opioid Analgesics Sales by Region: 2020-2031

3.2.1 Global Opioid Analgesics Sales by Region: 2020-2025

3.2.2 Global Opioid Analgesics Sales by Region: 2026-2031

3.3 Global Opioid Analgesics Revenue by Region: 2020-2031

3.3.1 Global Opioid Analgesics Revenue by Region: 2020-2025

3.3.2 Global Opioid Analgesics Revenue by Region: 2026-2031

3.4 North America Opioid Analgesics Market Facts & Figures by Country

3.4.1 North America Opioid Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Opioid Analgesics Sales by Country (2020-2031)

3.4.3 North America Opioid Analgesics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Opioid Analgesics Market Facts & Figures by Country

3.5.1 Europe Opioid Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Opioid Analgesics Sales by Country (2020-2031)

3.5.3 Europe Opioid Analgesics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Opioid Analgesics Market Facts & Figures by Region

3.6.1 Asia Pacific Opioid Analgesics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Opioid Analgesics Sales by Region (2020-2031)

3.6.3 Asia Pacific Opioid Analgesics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Opioid Analgesics Market Facts & Figures by Country

3.7.1 Latin America Opioid Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Opioid Analgesics Sales by Country (2020-2031)

3.7.3 Latin America Opioid Analgesics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Opioid Analgesics Market Facts & Figures by Country

3.8.1 Middle East and Africa Opioid Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Opioid Analgesics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Opioid Analgesics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Opioid Analgesics Sales by Type (2020-2031)

4.1.1 Global Opioid Analgesics Sales by Type (2020-2025)

4.1.2 Global Opioid Analgesics Sales by Type (2026-2031)

4.1.3 Global Opioid Analgesics Sales Market Share by Type (2020-2031)

4.2 Global Opioid Analgesics Revenue by Type (2020-2031)

4.2.1 Global Opioid Analgesics Revenue by Type (2020-2025)

4.2.2 Global Opioid Analgesics Revenue by Type (2026-2031)

4.2.3 Global Opioid Analgesics Revenue Market Share by Type (2020-2031)

4.3 Global Opioid Analgesics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Opioid Analgesics Sales by Application (2020-2031)

5.1.1 Global Opioid Analgesics Sales by Application (2020-2025)

5.1.2 Global Opioid Analgesics Sales by Application (2026-2031)

5.1.3 Global Opioid Analgesics Sales Market Share by Application (2020-2031)

5.2 Global Opioid Analgesics Revenue by Application (2020-2031)

5.2.1 Global Opioid Analgesics Revenue by Application (2020-2025)

5.2.2 Global Opioid Analgesics Revenue by Application (2026-2031)

5.2.3 Global Opioid Analgesics Revenue Market Share by Application (2020-2031)

5.3 Global Opioid Analgesics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer Inc.

6.1.1 Pfizer Inc. Company Information

6.1.2 Pfizer Inc. Description and Business Overview

6.1.3 Pfizer Inc. Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Inc. Opioid Analgesics Product Portfolio

6.1.5 Pfizer Inc. Recent Developments/Updates

6.2 Abbott Laboratories

6.2.1 Abbott Laboratories Company Information

6.2.2 Abbott Laboratories Description and Business Overview

6.2.3 Abbott Laboratories Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Laboratories Opioid Analgesics Product Portfolio

6.2.5 Abbott Laboratories Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Company Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Johnson & Johnson Opioid Analgesics Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Company Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novartis AG Opioid Analgesics Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 Bayer AG

6.5.1 Bayer AG Company Information

6.5.2 Bayer AG Description and Business Overview

6.5.3 Bayer AG Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bayer AG Opioid Analgesics Product Portfolio

6.5.5 Bayer AG Recent Developments/Updates

6.6 GlaxoSmithKline plc

6.6.1 GlaxoSmithKline plc Company Information

6.6.2 GlaxoSmithKline plc Description and Business Overview

6.6.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio

6.6.5 GlaxoSmithKline plc Recent Developments/Updates

6.7 F. Hoffmann-La Roche AG

6.7.1 F. Hoffmann-La Roche AG Company Information

6.7.2 F. Hoffmann-La Roche AG Description and Business Overview

6.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio

6.7.5 F. Hoffmann-La Roche AG Recent Developments/Updates

6.8 Boehringer Ingelheim International GmbH

6.8.1 Boehringer Ingelheim International GmbH Company Information

6.8.2 Boehringer Ingelheim International GmbH Description and Business Overview

6.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio

6.8.5 Boehringer Ingelheim International GmbH Recent Developments/Updates

6.9 Bausch Health

6.9.1 Bausch Health Company Information

6.9.2 Bausch Health Description and Business Overview

6.9.3 Bausch Health Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bausch Health Opioid Analgesics Product Portfolio

6.9.5 Bausch Health Recent Developments/Updates

6.10 Sanofi S.A.

6.10.1 Sanofi S.A. Company Information

6.10.2 Sanofi S.A. Description and Business Overview

6.10.3 Sanofi S.A. Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sanofi S.A. Opioid Analgesics Product Portfolio

6.10.5 Sanofi S.A. Recent Developments/Updates

6.11 Teva Pharmaceuticals

6.11.1 Teva Pharmaceuticals Company Information

6.11.2 Teva Pharmaceuticals Description and Business Overview

6.11.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio

6.11.5 Teva Pharmaceuticals Recent Developments/Updates

6.12 Purdue Pharmaceuticals L.P.

6.12.1 Purdue Pharmaceuticals L.P. Company Information

6.12.2 Purdue Pharmaceuticals L.P. Description and Business Overview

6.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio

6.12.5 Purdue Pharmaceuticals L.P. Recent Developments/Updates

6.13 Endo International Plc

6.13.1 Endo International Plc Company Information

6.13.2 Endo International Plc Description and Business Overview

6.13.3 Endo International Plc Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Endo International Plc Opioid Analgesics Product Portfolio

6.13.5 Endo International Plc Recent Developments/Updates

6.14 Assertio Holdings, Inc

6.14.1 Assertio Holdings, Inc Company Information

6.14.2 Assertio Holdings, Inc Description and Business Overview

6.14.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio

6.14.5 Assertio Holdings, Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Opioid Analgesics Industry Chain Analysis

7.2 Opioid Analgesics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Opioid Analgesics Production Mode & Process Analysis

7.4 Opioid Analgesics Sales and Marketing

7.4.1 Opioid Analgesics Sales Channels

7.4.2 Opioid Analgesics Distributors

7.5 Opioid Analgesics Customer Analysis

8 Opioid Analgesics Market Dynamics

8.1 Opioid Analgesics Industry Trends

8.2 Opioid Analgesics Market Drivers

8.3 Opioid Analgesics Market Challenges

8.4 Opioid Analgesics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Boehringer Ingelheim International GmbH

Bausch Health

Sanofi

Teva Pharmaceuticals

Purdue Pharmaceuticals L.P.

Endo International Plc.

Assertio Holdings, Inc

Abbott Laboratories

List of Tables

Table 1. Global Opioid Analgesics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Opioid Analgesics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Opioid Analgesics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Opioid Analgesics Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Opioid Analgesics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Opioid Analgesics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Opioid Analgesics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Opioid Analgesics Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Opioid Analgesics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Opioid Analgesics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Opioid Analgesics, Product Type & Application

Table 12. Global Key Manufacturers of Opioid Analgesics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Analgesics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Opioid Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Opioid Analgesics Sales by Region (2020-2025) & (Tons)

Table 18. Global Opioid Analgesics Sales Market Share by Region (2020-2025)

Table 19. Global Opioid Analgesics Sales by Region (2026-2031) & (Tons)

Table 20. Global Opioid Analgesics Sales Market Share by Region (2026-2031)

Table 21. Global Opioid Analgesics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Opioid Analgesics Revenue Market Share by Region (2020-2025)

Table 23. Global Opioid Analgesics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Opioid Analgesics Revenue Market Share by Region (2026-2031)

Table 25. North America Opioid Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Opioid Analgesics Sales by Country (2020-2025) & (Tons)

Table 27. North America Opioid Analgesics Sales by Country (2026-2031) & (Tons)

Table 28. North America Opioid Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Opioid Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Opioid Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Opioid Analgesics Sales by Country (2020-2025) & (Tons)

Table 32. Europe Opioid Analgesics Sales by Country (2026-2031) & (Tons)

Table 33. Europe Opioid Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Opioid Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Opioid Analgesics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Opioid Analgesics Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Opioid Analgesics Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Opioid Analgesics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Opioid Analgesics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Opioid Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Opioid Analgesics Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Opioid Analgesics Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Opioid Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Opioid Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Opioid Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Opioid Analgesics Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Opioid Analgesics Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Opioid Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Opioid Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Opioid Analgesics Sales (Tons) by Type (2020-2025)

Table 51. Global Opioid Analgesics Sales (Tons) by Type (2026-2031)

Table 52. Global Opioid Analgesics Sales Market Share by Type (2020-2025)

Table 53. Global Opioid Analgesics Sales Market Share by Type (2026-2031)

Table 54. Global Opioid Analgesics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Opioid Analgesics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Opioid Analgesics Revenue Market Share by Type (2020-2025)

Table 57. Global Opioid Analgesics Revenue Market Share by Type (2026-2031)

Table 58. Global Opioid Analgesics Price (US$/Ton) by Type (2020-2025)

Table 59. Global Opioid Analgesics Price (US$/Ton) by Type (2026-2031)

Table 60. Global Opioid Analgesics Sales (Tons) by Application (2020-2025)

Table 61. Global Opioid Analgesics Sales (Tons) by Application (2026-2031)

Table 62. Global Opioid Analgesics Sales Market Share by Application (2020-2025)

Table 63. Global Opioid Analgesics Sales Market Share by Application (2026-2031)

Table 64. Global Opioid Analgesics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Opioid Analgesics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Opioid Analgesics Revenue Market Share by Application (2020-2025)

Table 67. Global Opioid Analgesics Revenue Market Share by Application (2026-2031)

Table 68. Global Opioid Analgesics Price (US$/Ton) by Application (2020-2025)

Table 69. Global Opioid Analgesics Price (US$/Ton) by Application (2026-2031)

Table 70. Pfizer Inc. Company Information

Table 71. Pfizer Inc. Description and Business Overview

Table 72. Pfizer Inc. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Pfizer Inc. Opioid Analgesics Product

Table 74. Pfizer Inc. Recent Developments/Updates

Table 75. Abbott Laboratories Company Information

Table 76. Abbott Laboratories Description and Business Overview

Table 77. Abbott Laboratories Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Abbott Laboratories Opioid Analgesics Product

Table 79. Abbott Laboratories Recent Developments/Updates

Table 80. Johnson & Johnson Company Information

Table 81. Johnson & Johnson Description and Business Overview

Table 82. Johnson & Johnson Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Johnson & Johnson Opioid Analgesics Product

Table 84. Johnson & Johnson Recent Developments/Updates

Table 85. Novartis AG Company Information

Table 86. Novartis AG Description and Business Overview

Table 87. Novartis AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Novartis AG Opioid Analgesics Product

Table 89. Novartis AG Recent Developments/Updates

Table 90. Bayer AG Company Information

Table 91. Bayer AG Description and Business Overview

Table 92. Bayer AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Bayer AG Opioid Analgesics Product

Table 94. Bayer AG Recent Developments/Updates

Table 95. GlaxoSmithKline plc Company Information

Table 96. GlaxoSmithKline plc Description and Business Overview

Table 97. GlaxoSmithKline plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline plc Opioid Analgesics Product

Table 99. GlaxoSmithKline plc Recent Developments/Updates

Table 100. F. Hoffmann-La Roche AG Company Information

Table 101. F. Hoffmann-La Roche AG Description and Business Overview

Table 102. F. Hoffmann-La Roche AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. F. Hoffmann-La Roche AG Opioid Analgesics Product

Table 104. F. Hoffmann-La Roche AG Recent Developments/Updates

Table 105. Boehringer Ingelheim International GmbH Company Information

Table 106. Boehringer Ingelheim International GmbH Description and Business Overview

Table 107. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Boehringer Ingelheim International GmbH Opioid Analgesics Product

Table 109. Boehringer Ingelheim International GmbH Recent Developments/Updates

Table 110. Bausch Health Company Information

Table 111. Bausch Health Description and Business Overview

Table 112. Bausch Health Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Bausch Health Opioid Analgesics Product

Table 114. Bausch Health Recent Developments/Updates

Table 115. Sanofi S.A. Company Information

Table 116. Sanofi S.A. Description and Business Overview

Table 117. Sanofi S.A. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Sanofi S.A. Opioid Analgesics Product

Table 119. Sanofi S.A. Recent Developments/Updates

Table 120. Teva Pharmaceuticals Company Information

Table 121. Teva Pharmaceuticals Description and Business Overview

Table 122. Teva Pharmaceuticals Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Teva Pharmaceuticals Opioid Analgesics Product

Table 124. Teva Pharmaceuticals Recent Developments/Updates

Table 125. Purdue Pharmaceuticals L.P. Company Information

Table 126. Purdue Pharmaceuticals L.P. Description and Business Overview

Table 127. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Purdue Pharmaceuticals L.P. Opioid Analgesics Product

Table 129. Purdue Pharmaceuticals L.P. Recent Developments/Updates

Table 130. Endo International Plc Company Information

Table 131. Endo International Plc Description and Business Overview

Table 132. Endo International Plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Endo International Plc Opioid Analgesics Product

Table 134. Endo International Plc Recent Developments/Updates

Table 135. Assertio Holdings, Inc Company Information

Table 136. Assertio Holdings, Inc Description and Business Overview

Table 137. Assertio Holdings, Inc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. Assertio Holdings, Inc Opioid Analgesics Product

Table 139. Assertio Holdings, Inc Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Opioid Analgesics Distributors List

Table 143. Opioid Analgesics Customers List

Table 144. Opioid Analgesics Market Trends

Table 145. Opioid Analgesics Market Drivers

Table 146. Opioid Analgesics Market Challenges

Table 147. Opioid Analgesics Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Opioid Analgesics

Figure 2. Global Opioid Analgesics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Opioid Analgesics Market Share by Type: 2024 & 2031

Figure 4. OxyContin Product Picture

Figure 5. Vicodin Product Picture

Figure 6. Morphine Product Picture

Figure 7. Methadone Product Picture

Figure 8. Others Product Picture

Figure 9. Global Opioid Analgesics Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Opioid Analgesics Market Share by Application: 2024 & 2031

Figure 11. Surgical Pain

Figure 12. Cancer Pain

Figure 13. Neuropathic Pain

Figure 14. Others

Figure 15. Global Opioid Analgesics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Opioid Analgesics Market Size (2020-2031) & (US$ Million)

Figure 17. Global Opioid Analgesics Sales (2020-2031) & (Tons)

Figure 18. Global Opioid Analgesics Average Price (US$/Ton) & (2020-2031)

Figure 19. Opioid Analgesics Report Years Considered

Figure 20. Opioid Analgesics Sales Share by Manufacturers in 2024

Figure 21. Global Opioid Analgesics Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Opioid Analgesics Players: Market Share by Revenue in Opioid Analgesics in 2024

Figure 23. Opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Opioid Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Opioid Analgesics Sales Market Share by Country (2020-2031)

Figure 26. North America Opioid Analgesics Revenue Market Share by Country (2020-2031)

Figure 27. United States Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Opioid Analgesics Sales Market Share by Country (2020-2031)

Figure 30. Europe Opioid Analgesics Revenue Market Share by Country (2020-2031)

Figure 31. Germany Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Opioid Analgesics Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Opioid Analgesics Revenue Market Share by Region (2020-2031)

Figure 38. China Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Opioid Analgesics Sales Market Share by Country (2020-2031)

Figure 48. Latin America Opioid Analgesics Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Opioid Analgesics Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Opioid Analgesics Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Opioid Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Opioid Analgesics by Type (2020-2031)

Figure 58. Global Revenue Market Share of Opioid Analgesics by Type (2020-2031)

Figure 59. Global Opioid Analgesics Price (US$/Ton) by Type (2020-2031)

Figure 60. Global Sales Market Share of Opioid Analgesics by Application (2020-2031)

Figure 61. Global Revenue Market Share of Opioid Analgesics by Application (2020-2031)

Figure 62. Global Opioid Analgesics Price (US$/Ton) by Application (2020-2031)

Figure 63. Opioid Analgesics Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Opioid Analgesics Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-17G15089

Global Opioid Analgesics Market Research Report 2025

FEATURED COMPANIES

Opioid Analgesics Market Size

Opioid Analgesics Market

Report Scope

Scope of Opioid Analgesics Market Report

Core Chapters

FAQ for this report

How fast is Opioid Analgesics Market growing?

What is the Opioid Analgesics Market size in 2031?

Who are the main players in the Opioid Analgesics Market report?

What are the Application segmentation covered in the Opioid Analgesics Market report?

What are the Type segmentation covered in the Opioid Analgesics Market report?

FEATURED COMPANIES

Covid 19 Impact on Global HFO 1234yf Market Size Status and Forecast 2020 2026

Single User, Electronic (PDF)